30
Jan 2026
John F. Kelly, PhD, of the Recovery Research Institute and Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in Frontiers in Public Health, "Long-term relapse: markers, mechanisms, and implications for disease management in alcohol use disorder."
30
Jan 2026
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest forms of cancer.
30
Jan 2026
Cancer patients who suffer a heart attack face a dangerous mix of risks, which makes their clinical treatment particularly challenging.
30
Jan 2026
Artificial intelligence (AI)-supported mammography identifies more cancers during screening and reduces the rate of breast cancer diagnosis by 12% in the years following, finds the first randomised controlled trial of its kind involving over 100,000 Swedish women published in The Lancet journal.
30
Jan 2026
WHO has designated the DTU National Food Institute to host a new collaborating center, named "WHO Collaborating center for Risks and Benefits of Foods and Diets".
30
Jan 2026
Endoscopic optical coherence tomography is widely used to visualize tissue microstructures in real time, but current probes face clear limitations.
30
Jan 2026
Eggs as functional foods: this review explores enrichment techniques that enhance nutrient bioavailability and support health through precision nutrition.
30
Jan 2026
A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks.
30
Jan 2026
If severe DNA damage is not repaired, the consequences for the health of cells and tissues are dramatic.
30
Jan 2026
New research by UCLA Health and UC San Francisco has uncovered why certain brain cells are more resilient than others to the buildup of a toxic protein that is a hallmark of Alzheimer's disease and related dementias, potentially leading to new targets for therapies or treatments.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
